Bristol-Myers Squibb Company Kemudahan penyelidikan dan pembangunan Bristol-Myers Squibb di Lawrence, New Jersey
Jenis/bentuk sah Awam Didagangkan sebagai NYSE : BMY Komponen S&P 100 Komponen S&P 500ISIN US1101221083 Industri Farmaseutikal Ditubuhkan 1887, penggabungan 1989 Ibu pejabat 345 Park Avenue New York, New York, Amerika Syarikat Tokoh penting Giovanni Caforio, M.D. (Pengerusi & CEO) Charles Bancroft (CFO) Hasil ▲ US$ 20.78 bilion (2017) Pendapatan kendalian ▼ US$ 5.13 bilion (2017) Pendapatan bersih ▼ US$ 975 juta (2017) Jumlah aset ▼ US$ 33.55 bilion (2017) Jumlah ekuiti ▼ US$ 11.85 bilion (2017) Bilangan kakitangan ~23,700 (2017) Anak syarikat Bristol-Myers Squibb (Japan), Bristol Myers Squibb (Canada), Bristol-Myers Squibb (India), Kosan Biosciences, Bristol-Myers Squibb (Germany) Tapak web www.bms.com Catatan kaki/rujukan [ 1] sunting · sunting di Wikidata Lihat pendokumenan templat ini
Bristol-Myers Squibb (BMS ) ialah sebuah syarikat farmaseutikal Amerika, yang beribu pejabat di New York City.
Bristol-Myers Squibb mengeluarkan ubat-ubatan dan biologi preskripsi di beberapa kawasan terapeutik , termasuk kanser , HIV/AIDS , penyakit kardiovaskular , diabetes , hepatitis , rheumatoid arthritis dan gangguan psikiatri .
Tapak R&D utama BMS terletak di Lawrence, New Jersey (dahulunya Squibb, dekat Princeton) dan Wallingford, Connecticut (dahulunya Bristol-Myers); dengan tapak lain di Syracuse Timur, New York ; Princeton Pike, Perbandaran Hopewell dan New Brunswick, New Jersey; dan di Swords, Ireland ; Braine-l'Alleud, Belgium ; Tokyo , Jepun ; dan Bangalore , India .[ 2]
Rujukan ^ "US SEC: Form 10-K Bristol-Myers Squibb Company". U.S. Securities and Exchange Commission. Dicapai pada February 17, 2018 . ^ "Bristol-Myers Squibb and Biocon's Syngene open new R&D Facility at Biocon Park". Diarkibkan daripada yang asal pada 29 September 2012. Dicapai pada 16 Mei 2012 .
Pautan luar "Bristol-Myers Squibb donates $6.9 million to benefit cancer patient". Drugstorenews.com. Diarkibkan daripada yang asal pada 2016-03-04. Dicapai pada 2018-10-03 . Syarikat farmaseutikal Amerika Syarikat
Kini Abbott Laboratories Acorda Therapeutics Aderis Advaxis Alcon Alexion Alkermes Alnylam Amgen Avax Technologies Baxter BioCryst Biogen Bioverativ Biovest Biovista Bristol-Myers Squibb Century Ceragenix Combe CytoSport CytRx Danco Laboratories Eli Lilly Galena Biopharma Genentech Gilead Sciences Ionis Institute for OneWorld Health Intercept Johnson & Johnson Ethicon Janssen Biotech McNeil Consumer Healthcare Ortho-McNeil Kinetic Concepts McKesson Melinta Therapeutics Melior Discovery Mentholatum Merck & Co. Myriad Genetics Northwest Biotherapeutics Norwich Pharma NovaBay Ovation Pfizer Pharmaceutical Product Development Prasco Laboratories Procter & Gamble Proteon Therapeutics Purdue Pharma Quark Regeneron RespireRx Sarepta Therapeutics Savage Laboratories Sheffield Spectrum Tec Laboratories Titan Trevena Inc Upsher-Smith Ventria Bioscience Vertex West Pharmaceutical Services Terdahulu
Penyongsangan cukai Ireland Activis plc (Ireland, 2013) Alkermes plc (Ireland, 2011) Allergan plc (Ireland, 2015) Covidien plc (Ireland, 2007) Endo International plc (Ireland, 2014) Horizon Pharma plc (Ireland, 2014) Jazz Pharmaceuticals plc, (Ireland, 2012) Mallinckrodt plc, (Ireland, 2013) Perrigo Company plc, (Ireland, 2013) Bukan penyongsangan cukai Ireland Bausch Health (Kanada, 2010) Bukan penyongsangan cukai ALZA Amylin ARIAD Barr Biolex Bradley CancerVax Cephalon CoTherix Covance Cubist Cutter Laboratories DNAPrint Genomics Epix Forest Laboratories Genta ImClone Systems ISTA King KV Leiner Health Products Martek Biosciences Massengill Miles Laboratories Naurex Nereus Nuvelo Organon Ortho OSI Parke-Davis Repros Therapeutics Qualitest Rib-X Schering-Plough Smith, Kline & French Sterling Drug Tanox TAP Trubion Upjohn Verus Vion ViroPharma Wyeth Zonite